Mei Gao
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals (NCT07712042) | Mei Gao | 2026-08-01 |
| Factors Related to the Progression of Non-target Coronary Lesions (NCT06248138) | Mei Gao | 2024-02-01 |
Track Mei Gao automatically
Every clearance here is in the API, with alerts when new ones post.